SS Innovations International, Inc. (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be prominently featured at the 2026 Society of Robotic Surgery (SRS) Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The system will be on display throughout the event and will be highlighted in multiple breakout sessions. A key demonstration will involve a live broadcast of a remote partial nephrectomy, performed by Dr. Amitabh Singh from the company's headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava is slated to participate as a speaker and panelist in several sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. The company's presence at the SRS meeting underscores its commitment to advancing robotic surgery and expanding its reach.
As of July 6, 2026, the SSi Mantra system has been utilized in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries. Approximately 2,100 physicians have been trained on the platform, reflecting its growing acceptance and integration into surgical practices worldwide. For more details, the full press release is available at https://ibn.fm/YYYKE.
SS Innovations International develops innovative surgical robotic technologies with a mission to make robotic surgery affordable and accessible globally. The company's product range includes the SSi Mantra system and the SSi Mudra suite of surgical instruments, supporting a variety of procedures, including cardiac surgery. Headquartered in India but incorporated in the United States, SS Innovations aims to expand the global presence of its user-friendly and cost-effective solutions. The latest news and updates are available in the company's newsroom at https://ibn.fm/SSII.
The SRS annual meeting provides a platform for surgeons, researchers, and industry leaders to discuss advancements in robotic surgery. SS Innovations' participation highlights the growing importance of telesurgery and the potential for robotic systems to improve access to specialized surgical care. The live demonstration of a remote partial nephrectomy exemplifies the capabilities of the SSi Mantra system in performing complex procedures across distances, which could have significant implications for healthcare delivery in underserved regions.
By showcasing its technology at this prestigious event, SS Innovations is positioning itself as a key player in the global robotic surgery market. The company's focus on affordability and training could accelerate the adoption of robotic surgery in emerging markets, potentially reducing disparities in surgical care. The extensive clinical experience with over 12,000 procedures and a wide range of procedure types demonstrates the versatility and reliability of the SSi Mantra system, which may encourage further adoption by hospitals and surgical centers worldwide.
